Evaluation of Hydroxychloroquine to Prevent CIPN
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Gynecologic Cancer|Early-stage Breast Cancer|Peripheral Neuropathy|Chemotherapy-induced Peripheral Neuropathy
Interventions: DRUG: Hydroxychloroquine
Sponsor: University of Arizona